In The Spotlight
DDNews Cancer Research Exclusive
Here's to more survivors
(Photo credit: National Cancer Institute)
Recent reports from cancer advocacy and research organizations detail an increase in cancer survivors, with incidence and mortality rates dropping in recent years
GlobalData notes in a recent report that oncology ranked as the top therapy field for non-industry sponsored clinical trials last year
BI and Trutino Biosciences to explore cancer immunology with novel cytokine platform
GRAIL announces validation of its multi-cancer early detection test in an article published in Annals of Oncology
Duke researchers employ a modified virus in animal studies to test possible vaccine that could stimulate natural immune attack against tumors
The AACR has announced a virtual meeting to be held on the original meeting dates
GEMoaB publishes preclinical proof-of-concept data on UniCAR-modified off-the-shelf natural killer cells
Five Prime Therapeutics publishes Phase 1 bemarituzumab study data in the Journal of Clinical Oncology
Start Codon joins Cancer Research UK’s Entrepreneurial Programmes Initiative
A look at gastroesophageal, gastric and colorectal cancer progress
by Martin Lachs/Brandon Fletcher
As excitement and investment related to adoptive cell transfer products increases, there are concerns and issues that need to be addressed in terms of long-term follow-up trials

by Sue Cramp, Charles River
In pursuit of new options for treating childhood cancers, a new approach to drug discovery and development may be an answer

by Andrea Toell of Lonza
Andrea Toell of Lonza shares how CAR T cells are transforming immuno-oncology

478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.